Source: Beximco Pharmaceuticals Ltd. (BXPHARMA) | FY 2011-12 | Page 85

(a) Salary and allowances include provident fund contribution of Tk. 12,805,617 (in 2011 Tk. 12,445,850).

(b) Delivery expense includes delivery support fee @ 2% of local Formulation and IV Fluid sales paid to I & I Services Ltd., a "Related Party".

(c) Repairs and maintenance includes maintenance of office, premises, vehicles, building, equipment and other infrastructures.

### 29. Other Income

Amount in Taka

| Particulars | Note | 2012 | 2011 |
|---|---|---|---|
| Interest on FDR & Short term Investment | | 437,201,038 | 330,494,566 |
| Dividend Income | | 456,945 | 200,000 |
| Royalty | | 3,499,537 | 2,997,369 |
| Exchange Rate Fluctuation Gain / (Loss) | | (1,055,025) | 5,178,032 |
| Profit on Sale of Fixed Assets (Note 35) | | 2,745,218 | 2,037,807 |
| **Total** | | **442,847,713** | **340,907,774** |

### 30. Finance Cost

| Particulars | Note | 2012 | 2011 |
|---|---|---|---|
| Interest on Working Capital Loan & Other Charges | | 284,529,283 | 253,005,544 |
| Interest on Project / Consortium Loan | | 235,182,666 | 213,074,009 |
| Interest on Lease Finance | | 48,268,802 | 38,853,739 |
| Interest on Loan from PF and WPP & Welfare Fund | | 77,425,824 | 62,712,465 |
| **Total** | | **645,406,575** | **567,645,757** |

### 31. Contribution to W P P & Welfare Funds

This represents statutory contribution by the company as per Bangladesh Labour law 2006.

The amount is conmputed @ 5% of net profit before tax (but after charging such contribution).

### 32. Income Tax Expenses

This consists of as follows :

| Particulars | Note | 2012 | 2011 |
|---|---|---|---|
| (i) Short provision earlier years | | 110,840,941 | 41,169,643 |
| (ii) Current Tax for the year under review (Note 3.9) | | 334,871,966 | 166,380,262 |
| (iii) Deferred Tax Expense (Note 3.9) | | 144,727,001 | 271,774,005 |
| **Total** | | **590,439,908** | **479,323,910** |

### 33. Earnings Per Share (EPS)

| Particulars | Note | 2012 | 2011 |
|---|---|---|---|
| (a) Earnings attributable to the Ordinary Shareholders (Tk.) | | 1,319,389,328 | 1,198,525,342 |
| (b) Weighted average number of Ordinary Shares outstanding during the year (Nos.) | | 304,639,050 | 304,639,050 |
| **Earnings Per Share (EPS) / Adjusted EPS (2011) (Tk.)** | | **4.33** | **3.93** |